9:05am ET
Investing
American Stocks Dominate Global Equities
More American companies are among the 20 largest in the world than at any time in the past decade. This is because earnings at U.S. companies have risen faster than the rest…
Companies
/Healthcare
Pfizer Inc
$28.09
▼ $0.22 (−0.76%) today
Markets open · 2:42pm ET
PFE Coverage
Page 79
9:02am ET
Investing
U.S. Stocks Open Lower Following Thursday Declines
While most of the 30 stocks on the Dow Jones Industrial closed in the red yesterday, Kraft Foods Inc. (NASDAQ: KFT) and Pfizer (NYSE: PFE) bucked that trend. Kraft climbed 0.71%, according…
8:04am ET
Health and Healthcare
Alzheimer’s Drug Shows Some Success (LLY, PFE, ELN)
Drugmaker Eli Lilly & Co. (NYSE: LLY) announced this morning that the company’s solanezumab treatment for Alzheimer’s disease failed to meet both the cognitive and functional endpoints in recently completed phase 3…
2:05pm ET
Health and Healthcare
Elan’s Spin-Off Creates Buyout Hopes (ELN, BIIB, ALKS, PFE)
Elan Corporation, plc (NYSE: ELN) may be surging on news that it is going to spin off its drug research unit, but now there is something else to consider. Elan could be getting…
8:29am ET
Health and Healthcare
Pfizer to Spin Off Animal Health Unit (PFE)
Drug maker Pfizer Inc. (NYSE: PFE) has filed a Form S-1 with the SEC for an initial public offering of the company’s animal health unit into a company to be called Zoetis…
Paul Ausick 11:31am ET
Health and Healthcare
Pfizer Settles Bribery Charges with Justice Dept., SEC
Drug maker Pfizer Inc. (NYSE: PFE) today announced that it has reached settlements with the US Justice Department and the Securities and Exchange Commission related to improper payments (aka, bribes) paid by…
Paul Ausick 6:34am ET
Investing
Media Digest (8/7/2012) Reuters, WSJ, NYT, FT, Bloomberg
Chesapeake Energy Corp. (NYSE: CHK) sells assets to improve earnings. (Reuters) Standard Chartered may lose its New York banking license over allegations it hid $250 billion in transactions tied to Iran. (Reuters) Acer…
5:44pm ET
Health and Healthcare
J&J, Pfizer Halt Development of Alzheimer’s Drug
Johnson & Johnson Inc. (NYSE: JNJ) and Pfizer Inc. (NYSE: PFE) both announced they are stopping development of a drug to treat patients with mild to moderate Alzheimer’s after the drug failed a…
4:17pm ET
Investing
24/7 Wall St. Closing Bell — July 31, 2012: Markets Turn Down on Lost Confidence, Eurozone Waffling
The three major US stock indexes opened mixed this morning following the unemployment report from the Eurozone, which showed that the 11.2% rate had remained unchanged. The Eurozone consumer price index was…
7:59am ET
Commodities & Metals
U.S. Stock Futures Edge Higher as Investors Await Fed Action
U.S. stocks are set to open higher on the final day of July. All three indexes are expected to post mild gains for the month. Futures on the Dow Jones Industrial Average…
7:36am ET
Health and Healthcare
Pfizer’s Profits Rise on Lower Revenues
Pfizer Inc. (NYSE: PFE) reported second-quarter adjusted earnings per share (EPS) of $0.62 and $15.06 billion in revenue this morning. Adjusted EPS was up from $0.59 in the same period a year…
Paul Ausick 12:33pm ET
Investing
Top Earnings Previews For This Week (AIG, ATVI, AWK, CMCSA, EA, FSLR, GMCR, KFT, PFE, PG, YELP)
Last week was a jam-packed week of earnings reports and this week has many key reports. We have provided earnings previews for 11 companies we expect to follow this week. Estimates are…
7:38am ET
Investing
Ten Must-Watch Events for the Week Ahead
The week ahead is going to be a busy week. There are many traditional events to watch, but by now the market participants and investors have learned that they have to pay…
11:23am ET
Health and Healthcare
Amarin Shares Fall Despite Regulatory OK
Usually, shares of drug makers soar following the announcement that the Foood and Drug Administration approved a drug. Amarin Corp. (NASDAQ: AMRN) announced approval by the FDA for Vascepta to patients very high…
7:21am ET
Health and Healthcare
Pfizer’s Alzheimer’s Drug Fails Trial
A new treatment for Alzheimer’s disease from Pfizer Inc. (NYSE: PFE) and partner Elan Corp. plc (NYSE: ELN) has failed a late-stage trial in patients with mild-to-moderate cases of the disease and…